|
Name |
13-hydroxymelleolide K
|
Molecular Formula | C23H27ClO7 | |
IUPAC Name* |
[(2R,2aS,4aR,7aR,7bR)-3-formyl-2a,4a-dihydroxy-6,6,7b-trimethyl-2,5,7,7a-tetrahydro-1H-cyclobuta[e]inden-2-yl] 3-chloro-4,6-dihydroxy-2-methylbenzoate
|
|
SMILES |
CC1=C(C(=CC(=C1Cl)O)O)C(=O)O[C@@H]2C[C@]3([C@@]2(C(=C[C@]4([C@@H]3CC(C4)(C)C)O)C=O)O)C
|
|
InChI |
InChI=1S/C23H27ClO7/c1-11-17(13(26)5-14(27)18(11)24)19(28)31-16-8-21(4)15-7-20(2,3)10-22(15,29)6-12(9-25)23(16,21)30/h5-6,9,15-16,26-27,29-30H,7-8,10H2,1-4H3/t15-,16-,21-,22+,23+/m1/s1
|
|
InChIKey |
YLRYEAULWVNKHX-ORDITMOKSA-N
|
|
Synonyms |
13-hydroxymelleolide K; SCHEMBL12242921
|
|
CAS | NA | |
PubChem CID | 53493214 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 450.9 | ALogp: | 3.7 |
HBD: | 4 | HBA: | 7 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 124.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 31 | QED Weighted: | 0.407 |
Caco-2 Permeability: | -5.039 | MDCK Permeability: | 0.00001580 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.151 |
Human Intestinal Absorption (HIA): | 0.016 | 20% Bioavailability (F20%): | 0.102 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.555 | Plasma Protein Binding (PPB): | 96.11% |
Volume Distribution (VD): | 0.962 | Fu: | 3.75% |
CYP1A2-inhibitor: | 0.256 | CYP1A2-substrate: | 0.511 |
CYP2C19-inhibitor: | 0.685 | CYP2C19-substrate: | 0.142 |
CYP2C9-inhibitor: | 0.778 | CYP2C9-substrate: | 0.588 |
CYP2D6-inhibitor: | 0.554 | CYP2D6-substrate: | 0.121 |
CYP3A4-inhibitor: | 0.804 | CYP3A4-substrate: | 0.253 |
Clearance (CL): | 9.243 | Half-life (T1/2): | 0.425 |
hERG Blockers: | 0.115 | Human Hepatotoxicity (H-HT): | 0.226 |
Drug-inuced Liver Injury (DILI): | 0.182 | AMES Toxicity: | 0.204 |
Rat Oral Acute Toxicity: | 0.247 | Maximum Recommended Daily Dose: | 0.954 |
Skin Sensitization: | 0.325 | Carcinogencity: | 0.827 |
Eye Corrosion: | 0.012 | Eye Irritation: | 0.562 |
Respiratory Toxicity: | 0.959 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001937 | 0.705 | D0C8HR | 0.248 | ||||
ENC005899 | 0.524 | D0R6RC | 0.235 | ||||
ENC003224 | 0.405 | D07DVK | 0.227 | ||||
ENC000887 | 0.386 | D02GAC | 0.225 | ||||
ENC005503 | 0.339 | D0E9KA | 0.224 | ||||
ENC003450 | 0.325 | D0P0HT | 0.222 | ||||
ENC003451 | 0.325 | D08NQZ | 0.221 | ||||
ENC003449 | 0.320 | D04GJN | 0.220 | ||||
ENC003838 | 0.320 | D0FL5V | 0.217 | ||||
ENC003839 | 0.320 | D0CW1P | 0.217 |